Related Experiment Video
Updated: Jul 17, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation
Xianyong Ma1, Matthew J Renda, Lin Wang
1Yale University School of Medicine, Department of Laboratory Medicine, P.O. Box 208035, 333 Cedar Street, New Haven, CT 06520-8035, USA.
Abstract:
RBM15 is the fusion partner with MKL in the t(1;22) translocation of acute megakaryoblastic leukemia. To understand the role of the RBM15-MKL1 fusion protein in leukemia, we must understand the normal functions of RBM15 and MKL. Here, we show a role for Rbm15 in myelopoiesis. Rbm15 is expressed at highest levels in hematopoietic stem cells and at more moderate levels during myelopoiesis of murine cell lines and primary murine cells. Decreasing Rbm15 levels with RNA interference enhances differentiation of the 32DWT18 myeloid precursor cell line. Conversely, enforced expression of Rbm15 inhibits 32DWT18 differentiation. We show that Rbm15 alters Notch-induced HES1 promoter activity in a cell type-specific manner. Rbm15 inhibits Notch-induced HES1 transcription in nonhematopoietic cells but stimulates this activity in hematopoietic cell lines, including 32DWT18 and human erythroleukemia cells. Moreover, the N terminus of Rbm15 coimmunoprecipitates with RBPJkappa, a critical factor in Notch signaling, and the Rbm15 N terminus has a dominant negative effect, impairing activation of HES1 promoter activity by full-length-Rbm15. Thus, Rbm15 is differentially expressed during hematopoiesis and may act to inhibit myeloid differentiation in hematopoietic cells via a mechanism that is mediated by stimulation of Notch signaling via RBPJkappa.
Insights
The RBM15 protein plays a key role in myelopoiesis, regulating myeloid cell differentiation. It influences Notch signaling, potentially inhibiting differentiation in hematopoietic cells.
Area of Science:
- Hematology
- Molecular Biology
- Cellular Differentiation
Background:
- RBM15 (RNA-binding protein 15) is a known fusion partner in acute megakaryoblastic leukemia.
- Understanding the normal function of RBM15 is crucial for elucidating its role in leukemia.
Purpose of the Study:
- To investigate the normal function of RBM15 in myelopoiesis.
- To determine the mechanism by which RBM15 influences hematopoietic cell differentiation.
Main Methods:
- RNA interference (RNAi) to decrease RBM15 levels.
- Enforced expression of RBM15.
- Analysis of Notch-induced HES1 promoter activity.
- Coimmunoprecipitation assays to study protein interactions.
Main Results:
- Rbm15 is highly expressed in hematopoietic stem cells and during myelopoiesis.
- Decreased Rbm15 enhances myeloid precursor cell differentiation, while enforced expression inhibits it.
- Rbm15 differentially regulates Notch-induced HES1 transcription in hematopoietic versus nonhematopoietic cells.
- The N-terminus of Rbm15 interacts with RBPJkappa and can inhibit HES1 promoter activity.
Conclusions:
- Rbm15 is differentially expressed during hematopoiesis.
- Rbm15 may inhibit myeloid differentiation by stimulating Notch signaling through RBPJkappa in hematopoietic cells.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Master Transcription Regulators
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
TGF - β Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells

